Cardiac manifestations of muscular dystrophies;Kardiale manifestationen bei muskeldystrophien

Zeitschrift fur Kardiologie

Volumn 94, Issue 5, 2005, Pages 312-320

  Perrot, A ^a   Spuler, S ^a   Geier, C ^a   Dietz, R ^a   Osterziel, K J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac involvement; Cardiomyopathy; Genetics; Muscular dystrophy; Myopathy

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HEART ARRHYTHMIA; HEART DILATATION; HEART MUSCLE; HUMAN; MUSCULAR DYSTROPHY; MYOCARDIAL DISEASE; MYOPATHY; MYOTONIC DYSTROPHY;

ARRHYTHMIA; CARDIOMYOPATHIES; CAUSE OF DEATH; COOPERATIVE BEHAVIOR; DEATH, SUDDEN, CARDIAC; GENOTYPE; HUMANS; MUSCULAR DYSTROPHIES; PATIENT CARE TEAM;

EID: 18844434160     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0232-3     Document Type: Article

References (41)

1. Seidman JG, Seidman C (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557-567
2. McNally E, Allikan M, Wheeler MT, Mislow JM, Heydemann A (2003) Cytoskeletal defects in cardiomyopathy. J Mol Cell Cardiol 35:231-241
3. Osterziel KJ, Scheffold T, Perrot A, Dietz R. (2001) Genetik der dilatativen Kardiomyopathie. Z Kardiol 90(7):461-469
4. Emery AE (1991) Population frequencies of inherited neuromuscular diseases - a world survey. Neuromusc Disord 1:19
5. De Visser M, Vermeulen M, Wokke JHJ (1999) Neuromusculaire ziekten. Elsevier/Bunge, Maarssen
6. Emery AE (2002) Muscular dystrophy into the new millennium. Neuromuscul Disord 12(4):343-349
7. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M. (1999) Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord 9(5):347-351
8. Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M. (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838-841
9. Hoogerwaard EM, de Voogt WG, Wilde AA, van der Wouw PA, Bakker E, van Ommen GJ, de Visser M (1997) Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J Neurol 244(10):657-663
10. Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, Di Somma S, Comi LI (1996) Development of Cardiomyopathy in Female Carriers Of Duchenne and Becker Muscular Dystrophies. Journal of the American Medical Association 275:1335-1338
11. Finsterer J, Gharehbaghi-Schnell E, Stollberger C, Fheodoroff K, Seiser A. (2001) Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy. Clin Genet 59(5):350-355
12. Lazarus A, Varin J, Ounnoughene Z, Radvanyi H, Junien C, Coste J, Laforet P, Eymard B, Becane HM, Weber S, Duboc D (1999) Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 99(8):1041-1046
13. Von zur Mühlen F, Klaas C, Kreuzer H, Mall G, Giese A, Reimers CD (1998) Cardiac involvement in proximal myopathy. Heart 79:619-621
14. Schoser, BGH (2004) Sudden cardiac death in myotonic dystrophy type 2. Neurology 63:2402-2404
15. Laforet P, de Toma C, Eymard B, Becane HM, Jeanpierre M, Fardeau M, Duboc D. (1998) Cardiac involvement in genetically confirmed facioscapulohumeral muscular dystrophy. Neurology 51(5):1454-1456
16. Stevenson WG, Perloff JK, Weiss JN, Anderson TL (1990) Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15(2):292-299
17. van der Kooi AJ, de Voogt WG, Barth PG, Busch HF, Jennekens FG, Jongen PJ, de Visser M. (1998) The heart in limb girdle muscular dystrophy. Heart 79(1):73-77
18. Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S, Nigro G, Rambaldi PF, Raia P, Pini A, Mora M, Giugliano MA, Esposito MG. (2001) Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 11(2):178-185
19. Becane HM, Bonne G, Varnous S, Muchir A, Ortega V, Hammouda EH, Urtizberea JA, Lavergne T, Fardeau M, Eymard B, Weber S, Schwartz K, Duboc D (2000) High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 23(11 Pt 1):1661-1666
20. Arbustini E, Pilotto A, Repetto A, Grasso M, Negri A, Diegoli M, Campana C, Scelsi L, Baldini E, Gavazzi A, Tavazzi L (2002) Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39(6):981-990
21. Sanoudou D, Beggs AH (2001) Clinical and genetic heterogeneity in nemaline myopathy - a disease of skeletal muscle thin filaments. Trends Mol Med 8:362-368
22. Ishibashi-Ueda H, Imakita M, Yutani C, Takahashi S, Yazawa K, Kamiya T, Nonaka I (1990) Congenital nemaline myopathy with dilated cardiomyopathy: an autopsy study. Hum Pathol 21:77-82
23. Smeiting J, van den Heiwel L, diMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342-52
24. Anan R, Kagakawa M, Miyata M, Higuchi I, Kakao S, Suehara M, Osame M, Tanak H (1995) Cardiac involvement in mitochondrial diseases. Circulation 91:955-961
25. Tanaka M, Ino H, Ohno K, Hattori K, Sato W, Ozawa T (1990) Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet 4:1452
26. Toda T, Kobayashi K, Kondo-Iida E, Sasaki J, Nakamura Y (2000) The Fukuyama congenital muscular dystrophy story. Neuromuscul Disord 10(3):153-159
27. Hayashi YK, Ogawa M, Tagawa K, Noguchi S, Ishihara T, Nonaka I, Arahata K (2001) Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57(1):115-121
28. Emery AE (2000) Emery-Dreifuss muscular dystrophy - a 40 year retrospective. Neuromuscul Disord 10(4-5):228-232
29. Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8(4):323-327
30. Bonne G, Di Barletta MR, Varnous S, Becane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285-288
31. Buckley AE, Dean J, Mahy IR (1999) Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series. Heart 82:105-108
32. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Jr, Spudich S, De Girolami U, Seidman JG, Seidman CE, Muntoni F, Muehle G, Johnson W, McDonough B (1999) Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease. New England Journal of Medicine 341:1715-1724
33. Sjoberg G, Saavedra Matiz CA, Rosen DR, Wijsman EM, Borg K, Horowitz SH, Sejersen T (1999) A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 8:2191-2198
34. Dalakas MC, Park KY, Semino Mora C, Lee HS, Sivakumar K, Goldfarb LG. (2000) Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. New England Journal of Medicine 342:770-780
35. Hackenberg T (1992) Heart transplantation in a patient with central core disease. J Cardiothorac Vasc Anaesth 6:386-387
36. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND (1993) Missense mutations in the b-myosin heavy chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90:3993-3997
37. Becher MW, Morrison L, Davis LE, Maki WC, King MK, Bicknell JM, Reinert BL, Bartolo C, Bear DG (2001) Oculopharyngeal muscular dystrophy in Hispanic New Mexicans. JAMA 286(19):2437-2440
38. Betz RC, Schoser BG, Kasper D, Ricker K, Ramirez A, Stein V, Torbergsen T, Lee YA, Nothen MM, Wienker TF, Malin JP, Propping P, Reis A, Mortier W, Jentsch TJ, Vorgerd M, Kubisch C (2001) Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 28(3):218-219
39. Hoppe UC, Erdmann E (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218-237
40. Himmrich E, Popov S, Liebrich A, Rosocha S, Zellerhoff C, Nowak B, Przibille O (2000) Verborgene intrakardiale Leitungsstörungen und deren spontaner Verlauf bei Patienten mit progressiver Muskeldystrophie. Z Kardiol 89:592-598
41. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL (2002) ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106:2145-2161